Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia
Gary J. Schiller, Susan M. O'Brien, Arnaud Pigneux, Daniel J. DeAngelo, Norbert Vey, Jonathan Kell, Scott Solomon, Robert K. Stuart, Verena Karsten, Ann L. Cahill, Maher X. Albitar, Francis J. Giles
Dive into the research topics of 'Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia'. Together they form a unique fingerprint.